Suzdak Peter David 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Feb 6, 2013
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Stock Option (right to purchase)
2013-02-04+1,200,000→ 1,200,000 totalExercise: $0.37From: 2013-02-04Exp: 2023-02-04→ Common Stock (1,200,000 underlying)